Transcatheter Occlusion of Patent Ductus Arteriosus With a New Detachable Coil System (DuctOcclud)

Oho, Shinichi; Ishizawa, Atsushi; Koike, Kazuhiko; Kobayashi, Toshiki; Nakanishi, Toshio; Momma, Kazuo; Ino, Toshihiro; Nishimoto, Kei; Ohkubo, Mataichi; Ono, Yasuo; Kamiya, Tetsuro; Akagi, Teiji; Kato, Hirohisa

doi:10.1253/jcj.62.489

Cited by 9 publications

(3 citation statements)

References 21 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Over all, the Rashkind double umbrella device was used in 399 patients, Gianturco coils in 599, detachable coils in 669, PFM coils in 765, and the Amplatzer occluder in 763 patients. 7,11,12,18,[26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] The results and complications for the five most commonly used devices are summarized in Table 2.…”

Section: Outcome After Transcatheter Closurementioning

confidence: 99%

Do we still need the surgeon to close the persistently patent arterial duct?

2006

View full text Add to dashboard Cite

Galal et al: Transcatheter closure of arterial duct 523 device reported by Rashkind and Cuaso. 6 Initial success with the Rashkind device suggested that it might well be the management of choice. The double umbrella, however, was unwieldy, and required a large bore sheath for its introduction. When used to close large ducts in small children, there was also a risk of causing left pulmonary arterial stenosis or aortic narrowing. Moreover, the device was suitable only if the narrowest diameter of the duct was less than 9 millimetres. About half of patients with persistently patent ducts, therefore, would have still needed surgical ligation. 7 By the early 1990s, Cambier et al. 8 had led the way in using Gianturco coils to close small ducts. Such coils were much less cumbersome than the umbrellas, and hence found rapid worldwide acceptance. But such coils were still of use only in smaller ducts, measuring less than three millimetres at their narrowest diameter. The closure of larger ducts using multiple coils was appealing, and often proved to be successful, but was associated with an increased risk of left pulmonary arterial stenosis, 9 and a relatively high rate of inadvertent embolization. 10 The introduction of the Cook detachable coil provided an even safer option, 11 and this device almost entirely replaced the Gianturco coil for closing small duct. Then, in 1993, the PFM coil was introduced for clinical use. It has since undergone several modifications, but clinical experience is now encouraging when it is used for closing the small and moderate patent arterial duct. 12 Despite these developments, the large ducts still remained in the domain of the surgeon. Rao et al., 13 as well as later Grifka et al., 14 designed devices to close such larger ducts, but neither device emerged as a significantly marketable option. It was the emergence of the Amplatzer duct occluder that expanded the options of the interventional cardiologist. This device is currently used safely and effectively for closure of ducts measuring up to 16 millimetres at their narrowest diameter.

show abstract

Section: Outcome After Transcatheter Closurementioning

confidence: 99%

Do we still need the surgeon to close the persistently patent arterial duct?

2006

View full text Add to dashboard Cite

show abstract

“…In children, hepatoportal arteriovenous fistulae [2] and coronary arteriovenous fistulae have been successfully occluded by coil embolisation [3], but the major indication for this procedure is occlusion of the persisting arterial duct [4,5,6]. In the first transcatheter coil embolisation, Fuhrman et al [7] used Gianturco steel coils with Dacron strands.…”

Section: Discussionmentioning

confidence: 99%

Biodegradation of tungsten embolisation coils used in children

Kampmann

Brzezinska

Abidini

et al. 2002

Pediatric Radiology

View full text Add to dashboard Cite

show abstract

“…These results compare to the 91% success achieved in a multi-centric study reported from Japan. 10 These high rates of success may stem from the fact that, in contrast to other types of devices used to close patent arterial ducts, each DuctOcclud device is chosen from a large range of available coils, so as to fit precisely the dimensions and morphology of each specific duct. Experience with other devices has shown that the patent lumen should be totally obliterated during catheterization, leaving no residual shunt, often necessitating placement of multiple coils.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous transcatheter occlusion of the patent arterial duct using the pfm DuctOcclud Coil® via a trans-aortic and trans-pulmonary approach

et al. 2002

View full text Add to dashboard Cite

Occlusion using coils is now the treatment of choice for closure of the patent arterial duct. The DuctOcclud (pfm AG, Cologne, Germany) device is a relatively new retrievable coil for such trans-catheter closure. This study expands on previously reported experience with this device, summarizes the advantages of the device, and compares trans-pulmonary and trans-aortic delivery in 47 patients. There were 27 females. The mean, and median, ages were 4.6, and 2.85 years, respectively. The youngest patient was aged 9 months, weighing 7 kg. A trans-aortic delivery was used in 41 cases, and a trans-pulmonary approach in 6 cases. Of the 47 procedures, 45 (96%) were successful at the first attempt. The other two patients were treated successfully at the second attempt, giving a 100% rate of success. The technical characteristics of the coil allowed for its repeated maneuvering until an optimal position was obtained prior to release. Closure was confirmed by lack of ductal flow by echo-doppler on follow- up echocardiography. No short- or long-term complications of the procedure were noted in any of the patients. We conclude that the DuctOcclud device is an effective and safe method for closure of the small-to-moderately patent arterial duct. In a large proportion of patients, trans-aortic delivery is the preferred approach.

show abstract

Transcatheter Occlusion of Patent Ductus Arteriosus With a New Detachable Coil System (DuctOcclud)

Cited by 9 publications

References 21 publications

Do we still need the surgeon to close the persistently patent arterial duct?

Do we still need the surgeon to close the persistently patent arterial duct?

Biodegradation of tungsten embolisation coils used in children

Percutaneous transcatheter occlusion of the patent arterial duct using the pfm DuctOcclud Coil® via a trans-aortic and trans-pulmonary approach

Contact Info

Product

Resources

About